Sign up to save your podcasts
Or
Share Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Host: Naim Alkhouri, MD, FAASLD, DABOM
MASLD/MASH is a serious, chronic, progressive disease that will soon be the most common indication for liver transplantation and a major driver of the development of liver cancer. The good news is we now have a recently approved liver-directed therapy. Tune in to ensure you know how to effectively identify and treat MASLD/MASH in your patients.
View all episodes
By ReachMDHost: Naim Alkhouri, MD, FAASLD, DABOM
MASLD/MASH is a serious, chronic, progressive disease that will soon be the most common indication for liver transplantation and a major driver of the development of liver cancer. The good news is we now have a recently approved liver-directed therapy. Tune in to ensure you know how to effectively identify and treat MASLD/MASH in your patients.